Advertisement

Cellular and Molecular Neurobiology

, Volume 36, Issue 6, pp 839–849 | Cite as

Expression of BDNF and TrkB Phosphorylation in the Rat Frontal Cortex During Morphine Withdrawal are NO Dependent

  • Danil I. Peregud
  • Alexander A. Yakovlev
  • Mikhail Yu. Stepanichev
  • Mikhail V. Onufriev
  • Leonid F. Panchenko
  • Natalia V. Gulyaeva
Original Research

Abstract

Nitric oxide (NO) mediates pharmacological effects of opiates including dependence and abstinence. Modulation of NO synthesis during the induction phase of morphine dependence affects manifestations of morphine withdrawal syndrome, though little is known about mechanisms underlying this phenomenon. Neurotrophic and growth factors are involved in neuronal adaptation during opiate dependence. NO-dependent modulation of morphine dependence may be mediated by changes in expression and activity of neurotrophic and/or growth factors in the brain. Here, we studied the effects of NO synthesis inhibition during the induction phase of morphine dependence on the expression of brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and insulin-like growth factor 1 (IGF1) as well as their receptors in rat brain regions after spontaneous morphine withdrawal in dependent animals. Morphine dependence in rats was induced within 6 days by 12 injections of morphine in increasing doses (10–100 mg/kg), and NO synthase inhibitor L-NG-nitroarginine methyl ester (L-NAME) (10 mg/kg) was given 1 h before each morphine injection. The expression of the BDNF, GDNF, NGF, IGF1, and their receptors in the frontal cortex, striatum, hippocampus, and midbrain was assessed 40 h after morphine withdrawal. L-NAME treatment during morphine intoxication resulted in an aggravation of the spontaneous morphine withdrawal severity. Morphine withdrawal was accompanied by upregulation of BDNF, IGF1, and their receptors TrkB and IGF1R, respectively, on the mRNA level in the frontal cortex, and only BDNF in hippocampus and midbrain. L-NAME administration during morphine intoxication decreased abstinence-induced upregulation of these mRNAs in the frontal cortex, hippocampus and midbrain. L-NAME prevented from abstinence-induced elevation of mature but not pro-form of BDNF polypeptide in the frontal cortex. While morphine abstinence did not affect TrkB protein levels as well as its phosphorylation status, inhibition of NO synthesis decreased levels of phosphorylated TrkB after withdrawal. Thus, NO signaling during induction of dependence may be involved in the mechanisms of BDNF expression and processing at abstinence, thereby affecting signaling through TrkB in the frontal cortex.

Keywords

Nitric oxide BDNF Rat brain Morphine dependence 

Notes

Acknowledgments

The study was supported by Russian Foundation for Basic Research Grant #10-04-01403 and 13-04-01415. The authors thank Natalia Lazareva and Natalia Stepanicheva for a superb technical support.

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. Adams ML, Kalicki JM, Meyer ER, Cicero TJ (1993) Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-l-arginine methyl ester. Life Sci 52:PL245–PL249CrossRefPubMedGoogle Scholar
  2. Aricioglu F, Paul IA, Regunathan S (2004) Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice. Neurosci Lett 354:153–157CrossRefPubMedGoogle Scholar
  3. Beitner-Johnson D, Nestler EJ (1993) Chronic morphine decreases insulin-like growth factor-I levels in the ventral tegmental area of the rat brain. Ann NY Acad Sci 692:246–248CrossRefPubMedGoogle Scholar
  4. Bhargava HN (1995) Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol 26:1049–1053CrossRefPubMedGoogle Scholar
  5. Bie B, Wang Y, Cai YQ et al (2012) Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward. Neuropsychopharmacology 37:2780–2788CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bläsig J, Herz A, Reinhold K, Zieglgänsberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19–38CrossRefPubMedGoogle Scholar
  7. Bondy CA, Cheng CM (2004) Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 490:25–31CrossRefPubMedGoogle Scholar
  8. Chen J, Zacharek A, Zhang C et al (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25:2366–2375CrossRefPubMedPubMedCentralGoogle Scholar
  9. Chen B, Strauch K, Jin Y et al (2014) Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells. Clin Exp Pharmacol Physiol 41:469–474CrossRefPubMedPubMedCentralGoogle Scholar
  10. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162:156–159CrossRefPubMedGoogle Scholar
  11. Contestabile A (2008) Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells. Prog Neurobiol 84:317–328CrossRefPubMedGoogle Scholar
  12. Dambisya YM, Lee TL (1996) Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 117:914–918CrossRefPubMedPubMedCentralGoogle Scholar
  13. Dehpour AR, Sadr SS, Nouroddini M et al (2000) Comparison of simultaneous administration of lithium with L-NAME or l-arginine on morphine withdrawal syndrome in mice. Hum Psychopharmacol 15:87–93CrossRefPubMedGoogle Scholar
  14. Dhakshinamoorthy S, Sridharan SR, Li L et al (2007) Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Res 35:5439–5451CrossRefPubMedPubMedCentralGoogle Scholar
  15. Dum J, Bläsig J, Herz A (1981) Buprenorphine: demonstration of physical dependence liability. Eur J Pharmacol 70:293–300CrossRefPubMedGoogle Scholar
  16. Gallo EF, Iadecola C (2011) Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. J Neurosci 31:6947–6955CrossRefPubMedPubMedCentralGoogle Scholar
  17. Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783–2802CrossRefPubMedPubMedCentralGoogle Scholar
  18. Ghazalpour A, Bennett B, Petyuk VA et al (2011) Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet 7:e1001393. doi: 10.1371/journal.pgen.1001393 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Gray K, Ellis V (2008) Activation of pro-BDNF by the pericellular serine protease plasmin. FEBS Lett 582:907–910CrossRefPubMedGoogle Scholar
  20. Greer P, Greenberg M (2008) From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59:846–860CrossRefPubMedGoogle Scholar
  21. Griffith OW, Kilbourn RG (1996) Nitric oxide synthase inhibitors: amino acids. Methods Enzymol 268:375–392CrossRefPubMedGoogle Scholar
  22. Gu Z, Kaul M, Yan B et al (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186–1190CrossRefPubMedGoogle Scholar
  23. Karmohapatra SK, Chakraborty K, Kahn NN, Sinha AK (2007) The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets. Am J Hematol 82:986–995CrossRefPubMedGoogle Scholar
  24. Koo JW, Mazei-Robison MS, Chaudhury D et al (2012) BDNF is a negative modulator of morphine action. Science 338:124–128CrossRefPubMedPubMedCentralGoogle Scholar
  25. Koo JW, Mazei-Robison MS, LaPlant Q et al (2015) Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nat Neurosci 18:415–422CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kurauchi Y, Hisatsune A, Isohama Y et al (2011) Midbrain dopaminergic neurons utilize nitric oxide/cyclic GMP signaling to recruit ERK that links retinoic acid receptor stimulation to up-regulation of BDNF. J Neurochem 116:323–333CrossRefPubMedGoogle Scholar
  27. Leza JC, Lizasoain I, Cuéllar B et al (1996) Correlation between brain nitric oxide synthase activity and opiate withdrawal. NaunynSchmiedebergs Arch Pharmacol 353:349–354CrossRefGoogle Scholar
  28. Li Y, Wang H, Niu L, Zhou Y (2007) Chronic morphine exposure alters the dendritic morphology of pyramidal neurons in visual cortex of rats. Neurosci Lett 418:227–231CrossRefPubMedGoogle Scholar
  29. Liu WT, Han Y, Liu YP et al (2010) Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice. J Neurosci 30:7613–7623CrossRefPubMedPubMedCentralGoogle Scholar
  30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408CrossRefPubMedGoogle Scholar
  31. Martínez-Ruiz A, Cadenas S, Lamas S (2011) Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic Biol Med 51:17–29CrossRefPubMedGoogle Scholar
  32. Mashayekhi FJ, Rasti M, Rahvar M et al (2012) Expression levels of the BDNF gene and histone modifications around its promoters in the ventral tegmental area and locus ceruleus of rats during forced abstinence from morphine. Neurochem Res 37:1517–1523CrossRefPubMedGoogle Scholar
  33. Messer CJ, Eisch AJ, Carlezon WA Jr et al (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26:247–257CrossRefPubMedPubMedCentralGoogle Scholar
  34. Mizoguchi H, Nakade J, Tachibana M et al (2011) Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. J Neurosci 31:12963–12971CrossRefPubMedGoogle Scholar
  35. Nemoto W, Sato T, Nakagawasai O et al (2013) Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice. Neuropeptides 47:187–191CrossRefPubMedGoogle Scholar
  36. Nott A, Watson PM, Robinson JD et al (2008) S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455:411–415CrossRefPubMedGoogle Scholar
  37. Pang PT, Teng HK, Zaitsev E et al (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306:487–491CrossRefPubMedGoogle Scholar
  38. Peregud DI, Yakovlev AA, Stepanichev M et al (2013) Role of NO/cGMP signaling cascade in the development of opium dependency. Eksp Klin Farmakol 76:3–6PubMedGoogle Scholar
  39. Peregud DI, Panchenko LF, Gulyaeva NV (2015) Elevation of BDNF exon I-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCreb1 occupancy at the corresponding promoter. Neurochem Res 40:130–138CrossRefPubMedGoogle Scholar
  40. Pfeiffer S, Leopold E, Schmidt K et al (1996) Inhibition of nitric oxide synthesis by NG-nitro-l-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-l-arginine. Br J Pharmacol 118:1433–1440CrossRefPubMedPubMedCentralGoogle Scholar
  41. Quirié A, Hervieu M, Garnier P et al (2012) Comparative effect of treadmill exercise on mature BDNF production in control versus stroke rats. PLoS One 7:e44218. doi: 10.1371/journal.pone.0044218 CrossRefPubMedPubMedCentralGoogle Scholar
  42. Rahman S, Ali Khan R, Kumar A (2002) Experimental study of the morphine de-addiction properties of Delphinium denudatum Wall. BMC Complement Altern Med 2:6. doi: 10.1186/1472-6882-2-6 CrossRefPubMedPubMedCentralGoogle Scholar
  43. Reisser D, Onier-Cherix N, Jeannin JF (2002) Arginase activity is inhibited by L-NAME, both in vitro and in vivo. J Enzyme Inhib Med Chem 17:267–270CrossRefPubMedGoogle Scholar
  44. Riccio A, Alvania RS, Lonze BE (2006) A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 21:283–294CrossRefPubMedGoogle Scholar
  45. Robertson CA, Green BG, Niedzwiecki L et al (1993) Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase. Biochem Biophys Res Commun 197:523–528CrossRefPubMedGoogle Scholar
  46. Robinson TE, Kolb B (1999) Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33:160–162CrossRefPubMedGoogle Scholar
  47. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56:73–82CrossRefPubMedGoogle Scholar
  48. Selvakumar B, Jenkins MA, Hussain NK et al (2013) S-nitrosylation of AMPA receptor GluA1 regulates phosphorylation, single-channel conductance, and endocytosis. Proc Natl Acad Sci USA 110:1077–1082CrossRefPubMedGoogle Scholar
  49. Selvakumar B, Campbell PW, Milovanovic M et al (2014) AMPA receptor upregulation in the nucleus accumbens shell of cocaine-sensitized rats depends upon S-nitrosylation of stargazin. Neuropharmacology 77:28–38CrossRefPubMedGoogle Scholar
  50. Shaw-Lutchman TZ, Barrot M, Wallace T et al (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 22:3663–3672PubMedGoogle Scholar
  51. Sklair-Tavron L, Shi WX, Lane SB et al (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 93:11202–11207CrossRefPubMedPubMedCentralGoogle Scholar
  52. Spiga S, Serra GP, Puddu MC, Foddai M, Diana M (2003) Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci 17:605–612CrossRefPubMedGoogle Scholar
  53. Toda N, Kishioka S, Hatano Y, Toda H (2009) Modulation of opioid actions by nitric oxide signaling. Anesthesiology 110:166–181CrossRefPubMedGoogle Scholar
  54. Uzbay IT, Oglesby MW (2001) Nitric oxide and substance dependence. Neurosci Biobehav Rev 25:43–52CrossRefGoogle Scholar
  55. Vargas-Perez H, Ting-A Kee R, Walton CH et al (2009) Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science 324:1732–1734CrossRefPubMedPubMedCentralGoogle Scholar
  56. Vaupel DB, Kimes AS, London ED (1997) Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol 324:11–20CrossRefPubMedGoogle Scholar
  57. Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13:227–232PubMedPubMedCentralGoogle Scholar
  58. Wan L, Xie Y, Su L et al (2011) RACK1 affects morphine reward via BDNF. Brain Res 1416:26–34CrossRefPubMedGoogle Scholar
  59. Wang WS, Kang S, Liu WT et al (2012) Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. J Neurosci 32:13763–13775CrossRefPubMedGoogle Scholar
  60. Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42:81–89CrossRefPubMedPubMedCentralGoogle Scholar
  61. Yu H, Hu H, Meng H et al (2011) Brain-derived neurotrophic factor and Bcl-2 expression in rat brain areas following chronic morphine treatment. Neural Regen Res 6:528–533Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Danil I. Peregud
    • 1
    • 2
  • Alexander A. Yakovlev
    • 2
  • Mikhail Yu. Stepanichev
    • 2
  • Mikhail V. Onufriev
    • 2
  • Leonid F. Panchenko
    • 1
    • 3
  • Natalia V. Gulyaeva
    • 2
  1. 1.Federal State Budgetary Institution “V. Serbsky Federal Medical Research Centre for Psychiatry and Drug Addiction”, of the Ministry of Health of the Russian FederationMoscowRussia
  2. 2.Institute of Higher Nervous Activity and NeurophysiologyRussian Academy of SciencesMoscowRussia
  3. 3.Institute of General Pathology and PathophysiologyRussian Academy of SciencesMoscowRussia

Personalised recommendations